Literature DB >> 19002345

PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse.

Sven Neynaber1, Nouhad Mistry-Burchardi, Christian Rust, Walter Samtleben, Walter H C Burgdorf, Michael Andreas Seitz, Gerald Messer, Andreas Wollenberg.   

Abstract

A 22-year-old man with a history of cocaine abuse from 2003 to 2005 developed recurrent bleeding of the nasal septum and a progressive cough and dyspnoea. He was admitted to the intensive care unit because of fulminant pneumonia, impaired renal function and progressive general deterioration. While hospitalized, he developed cutaneous vasculitis, thrombosis of the right subclavian and right jugular veins, testicular pain and, eventually, expanding red papules and plaques on the limbs. The symptoms were a diagnostic challenge, until skin biopsy showed immunoglobulin deposits in small vessels and kidney biopsy focal and segmental pauci-immune, crescentic glomerulonephritis. This led, together with anti-neutrophil cytoplasmic antibodies (cANCA and PR3-ANCA), to the diagnosis of Wegener granulomatosis. The number of affected organ systems in our patient exceeds that commonly found in the literature. Several clinical observations of cocaine abuse followed by Wegener granulomatosis suggest an active induction of a PR3-ANCA-positive vasculitis by cocaine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19002345     DOI: 10.2340/00015555-0514

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  14 in total

Review 1.  Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature.

Authors:  Shuchi Gulati; Anthony A Donato
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

2.  A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine.

Authors:  Rachel L Gross; Jason Brucker; Asena Bahce-Altuntas; Maria A Abadi; Jules Lipoff; David Kotlyar; Peter Barland; Chaim Putterman
Journal:  Clin Rheumatol       Date:  2011-06-25       Impact factor: 2.980

3.  Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease.

Authors:  Martina M McGrath; Tamara Isakova; Helmut G Rennke; Ann M Mottola; Karen A Laliberte; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

Review 4.  Systemic sclerosis induced by the use of cocaine: is there an association?

Authors:  Rafael Andreussi; Lila Morena Bueno Silva; Henrique Carriço da Silva; Ana Paula Luppino-Assad; Danieli Castro O Andrade; Percival D Sampaio-Barros
Journal:  Rheumatol Int       Date:  2018-12-15       Impact factor: 2.631

5.  Myocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis.

Authors:  Giuseppe Cocco; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

6.  Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report.

Authors:  Lourdes Roca-Argente; Jose-Luis Moll-Guillen; Jordi Espí-Reig; Marino Blanes-Julia; Ana-María García-Martínez; Conrad Pujol-Marco; Julio Hernández-Jaras
Journal:  Ann Transl Med       Date:  2015-10

Review 7.  Pathologic manifestations of levamisole-adulterated cocaine exposure.

Authors:  Amber L Nolan; Kuang-Yu Jen
Journal:  Diagn Pathol       Date:  2015-05-06       Impact factor: 2.644

8.  Fulminant primary manifestations of Wegener's granulomatosis might not be pauci-immune.

Authors:  Ulf Schönermarck; Maja Grahovac; Miklós Sárdy; Michael Dolch; Andreas Wollenberg
Journal:  NDT Plus       Date:  2010-08-05

9.  Cocaine-induced delayed recurrent vasculitis: a 4-year follow-up.

Authors:  Meera Yogarajah; Mona Pervil-Ulysse; Bhradeev Sivasambu
Journal:  Am J Case Rep       Date:  2015-05-24

10.  Levamisole-contaminated cocaine: an emergent cause of vasculitis and skin necrosis.

Authors:  Osama Souied; Hassan Baydoun; Zahraa Ghandour; Neville Mobarakai
Journal:  Case Rep Med       Date:  2014-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.